Savara Inc. Company Profile & Data: stocks, market cap, financials, digital and more

                        
Company
Savara Inc.Headquarters: Austin, 
                        TX, United States
                    
Employees: 27
CEO: Mr. Matthew  Pauls

                                    NASDAQ: SVRA
                                
                                            -8.19%
                                            
Market Cap$588.7 Million

                        USD as of Jan. 1, 2024
                    
                            Market Cap History

Savara Inc. Categories

United States Healthcare Biotechnology
United States Healthcare United States Biotechnology

Savara Inc. market capitalization over time

Evolution of Savara Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Savara Inc.

Top Competitors by Market Capitalization

Industry: Biotechnology

Company	Market Cap (USD)
Novo Nordisk	$461.52 B
Vertex Pharmaceuticals Incorporated	$107.23 B
Regeneron Pharmaceuticals, Inc.	$100.01 B
CSL Limited	$94.74 B
Marinomed Biotech AG	$73.23 B

Sector:

Company	Market Cap (USD)
Lilly	$586.39 B
UnitedHealth Group	$504.47 B
Novo Nordisk	$461.52 B
Johnson & Johnson	$387.50 B
Merck	$296.51 B

Detailed Description

Savara Inc. operates as an orphan lung disease company. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

Tweets by Savara Inc.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE